Channel Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:CHRO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Sep 24	BuyUS$5,044	Francis Knuettel	Individual	5,200	US$0.97
12 Sep 24	BuyUS$9,825	Richard Malamut	Individual	10,400	US$0.94
11 Sep 24	BuyUS$10,955	Francis Knuettel	Individual	12,000	US$0.94
21 Feb 24	BuyUS$100,002	Ezra Friedberg	Individual	16,667	US$6.00

Insider Buying: CHRO insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: CHRO only recently listed within the past 12 months

Top 20 shareholders own 75.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.6%	Ezra Friedberg	1,058,105	US$698.3k	1.6%	no data
12.4%	Chromocell Corporation	747,187	US$493.1k	0%	no data
8.02%	Motif Pharmaceuticals Limited	483,406	US$319.0k	0%	no data
7.82%	Boswell Prayer Ltd	471,592	US$311.3k	0%	no data
7.37%	Aperture Healthcare Ventures Ltd.	444,071	US$293.1k	0.23%	no data
6.37%	Benuvia Operations, LLC	384,226	US$253.6k	0%	no data
6.12%	AME Equities LLC	369,178	US$243.7k	0%	no data
4.54%	MDB Merchants Park LLC	273,776	US$180.7k	0%	no data
2.13%	Francis Knuettel	128,153	US$84.6k	-75.1%	no data
0.78%	Avantax Planning Partners, Inc.	47,205	US$31.2k	0%	no data
0.69%	Waxcap Inc.	41,666	US$27.5k	0%	no data
0.59%	3i Fund	35,625	US$23.5k	-88.8%	0.43%
0.48%	Todd Davis	29,167	US$19.3k	0%	no data
0.43%	Two Sigma Securities, LLC, Asset Management Arm	26,061	US$17.2k	0%	no data
0.17%	Wealth Enhancement Advisory Services, LLC	10,400	US$6.9k	0%	no data
0.17%	Richard Malamut	10,400	US$6.9k	0%	no data
0.083%	Geode Capital Management, LLC	5,011	US$3.3k	0%	no data
0.069%	Dominion Capital LLC	4,167	US$2.8k	0%	3.04%
0.0043%	Tower Research Capital Europe Limited	259	US$171.1	4,220%	no data
0.00018%	Bank of America Corporation, Asset Management Arm	11	US$7.2	22.2%	no data